HS
NPTN

HighVista Strategies’s NEOPHOTONICS CORP NPTN Stock Holding History

HighVista Strategies’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,633
Closed -$92K – 137
2021
Q3 		$92K Hold
10,633
– – 0.06% 111
2021
Q2 		$109K Buy
+10,633
New +$112K 0.08% 85
2021
Q1 		– Sell
-12,700
Closed -$115K – 150
2020
Q4 		$115K Hold
12,700
– – 0.07% 82
2020
Q3 		$77K Buy
+12,700
New +$96.9K 0.06% 95

Other funds holding NPTN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

HighVista Strategies's NPTN Position: Q4 2021 in Review

HighVista Strategies sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 10,633 shares — an estimated $92K sold.

HighVista Strategies first reported a position in NPTN in Q3 2020 and held it in 4 quarters. The position peaked at $115K in Q4 2020. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • HighVista Strategies reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 10,633 NEOPHOTONICS CORP shares in Q4 2021, an estimated $92K.
  • HighVista Strategies first reported a position in NEOPHOTONICS CORP in Q3 2020 and held it in 4 quarters.
  • HighVista Strategies's NEOPHOTONICS CORP position peaked at $115K in Q4 2020.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.